article thumbnail

Gelteq IPO: Supporting Gel Technology for Oral Drug Delivery

XTalks

per share, the offering included 1,300,000 ordinary shares, which began trading on the Nasdaq Global Market under the ticker symbol GELS on October 29, 2024. With an expanding patent portfolio and partnerships in human and animal health, Gelteq promotes therapeutic efficacy and patient adherence across diverse health markets.

article thumbnail

Pharmaceutical drug delivery market and systems

Pharmaceutical Technology

Download our free, comprehensive list of the leading companies within the pharmaceutical drug delivery market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

IoT innovation: Leading companies in nanoparticles for drug delivery

Pharmaceutical Technology

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Key innovation: Leading companies in nanoparticles for drug delivery. Bristol-Myers Squibb is the leading patent filer in nanoparticles for drug delivery.

article thumbnail

FDA Releases Draft Guidance on Essential Drug Delivery Outputs

FDA Law Blog

FDA recently released a much-anticipated draft guidance to address these frequent questions: Essential Drug Delivery Outputs for Devices Intended to Deliver Drugs and Biological Products. Drug delivery includes successful product preparation and the initiation, progression, and completion of dose delivery.

article thumbnail

Polyrizon IPO Strengthens Momentum in Non-Invasive Drug Delivery Solutions

XTalks

Trading began on the Nasdaq Capital Market under the ticker “PLRZ” on October 29, 2024. Additionally, a collaboration with NurExone is creating an intranasal delivery system for exosome-based therapies targeting spinal cord injuries, with potential expansion into other neurological uses. The IPO, priced at $4.38

article thumbnail

Halozyme, doubling down on a licensing strategy, buys a drug delivery biotech for nearly $1B

Bio Pharma Dive

Antares Pharma's auto-injector technology is of particular interest to Halozyme, which believes that the various markets to which it could be applied represent billions of dollars in potential sales.

article thumbnail

New Amazon Pharmacy TV Commercials Emphasize Hassle-Free Drug Delivery

XTalks

Amazon Pharmacy launched a pair of TV spots last month to showcase the ease of its drug delivery service for consumers. The service is an expansion of Amazon’s acquisition of PillPack in 2018, which provided a foundation for Amazon to enter the pharmaceutical market. billion this year. billion by 2029.